Guardant Health GH Licensing and other — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Guardant Health in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Guardant Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Guardant Health's licensing and other — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Guardant Health's licensing and other — total revenue?
- Guardant Health (GH) reported licensing and other — total revenue of $2.14M in Q1 2026.
- How has Guardant Health's licensing and other — total revenue changed year-over-year?
- Guardant Health's licensing and other — total revenue increased by 15.3% year-over-year, from $1.86M to $2.14M.
- What is the long-term trend for Guardant Health's licensing and other — total revenue?
- Over 2 years (2023 to 2025), Guardant Health's licensing and other — total revenue has grown at a -39.9% compound annual growth rate (CAGR), from $23.72M to $8.56M.
- What does licensing and other — total revenue mean?
- This metric represents the total revenue generated from non-core business activities, including the licensing of proprietary intellectual property, technology access fees, and other ancillary service agreements. It captures income streams that fall outside of the company's primary diagnostic testing and clinical service offerings. Monitoring this revenue helps assess the monetization of the company's research and development portfolio and its ability to extract value from strategic partnerships.